Elafin/Skalp Polyclonal antibody

Elafin/Skalp Polyclonal Antibody for IF, IHC, ELISA

Host / Isotype

Rabbit / IgG

Reactivity

human and More (1)

Applications

IF, IHC, ELISA

Conjugate

Unconjugated

Cat no : 15963-1-AP

Synonyms

cementoin, Elafin, Elastase specific inhibitor, ESI, Peptidase inhibitor 3, PI 3, PI3, Protease inhibitor WAP3, SKALP, WAP3, WFDC14



Tested Applications

Positive IHC detected inhuman skin cancer tissue, human oesophagus tissue, human oesophagus cancer tissue
Note: suggested antigen retrieval with TE buffer pH 9.0; (*) Alternatively, antigen retrieval may be performed with citrate buffer pH 6.0
Positive IF detected inHeLa cells

Recommended dilution

ApplicationDilution
Immunohistochemistry (IHC)IHC : 1:20-1:200
Immunofluorescence (IF)IF : 1:10-1:100
It is recommended that this reagent should be titrated in each testing system to obtain optimal results.
Sample-dependent, Check data in validation data gallery.

Published Applications

IHCSee 4 publications below

Product Information

15963-1-AP targets Elafin/Skalp in IF, IHC, ELISA applications and shows reactivity with human samples.

Tested Reactivity human
Cited Reactivityhuman, pig
Host / Isotype Rabbit / IgG
Class Polyclonal
Type Antibody
Immunogen Elafin/Skalp fusion protein Ag8735
Full Name peptidase inhibitor 3, skin-derived
Calculated Molecular Weight 117 aa, 12 kDa
GenBank Accession NumberBC010952
Gene Symbol PI3
Gene ID (NCBI) 5266
RRIDAB_2878201
Conjugate Unconjugated
Form Liquid
Purification MethodAntigen affinity purification
Storage Buffer PBS with 0.02% sodium azide and 50% glycerol pH 7.3.
Storage ConditionsStore at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. 20ul sizes contain 0.1% BSA.

Protocols

Product Specific Protocols
IHC protocol for Elafin/Skalp antibody 15963-1-APDownload protocol
IF protocol for Elafin/Skalp antibody 15963-1-APDownload protocol
Standard Protocols
Click here to view our Standard Protocols

Publications

SpeciesApplicationTitle
humanIHC

Ther Adv Med Oncol

Development and external validation of a composite immune-clinical prognostic model associated with EGFR mutation in East-Asian patients with lung adenocarcinoma.

Authors - Chengming Liu
pigIHC

Anim Biosci

Spatiotemporal expression and regulation of peptidase inhibitor 3 and secretory leukocyte protease inhibitor at the maternal-fetal interface in pigs

Authors - Soohyung Lee
humanIHC

Int J Gen Med

FAM3B Serves as a Biomarker for the Development and Malignancy of Oral Lichen Planus.

Authors - Wenfang Wang
humanIHC

Front Endocrinol (Lausanne)

Elafin is related to immune infiltration and could predict the poor prognosis in ovarian cancer

Authors - Weiyu Lu